Quidel Sofia 2 SARS Antigen+ FIA, 25 Tests

The next generation of COVID-19 rapid testing, Sofia 2 SARS Antigen+ Fluorescent Immunoassay (FIA), uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2.

Supplier:  Quidel 20405

Catalog No. 23-044-183

Description

• Results in 10 minutes
• Rapid results to support efficient dispositioning of patients
• Objective, accurate results
• Reliable results without cross-reactivity to seasonal coronaviruses
• Dual work modes
• Adjusts to your volume fluctuations. Allows for significant throughput and batching of samples in READ NOW Mode
• Virena connection
• Provides automated tracking, data capture, government reporting, and exclusive disease mapping
• Fluorescent technology with automated read
• Objective result that eliminates the subjectivity of a visual read
• All necessary components included in kit
• Ready for use with Sofia 2 for nasal swab procedure
• Self-contained Test Cassette
• Clean, easy to use and dispose of

Specifications

• Control Sets: Positive and Negative
• Clia Complexity: Waived
• Detection Method: Lateral Flow Technology
• Format: Cassette
• Sensitivity: PPA: 89%; NPA: 99.6%
• Disposable: Single-use
• No. of Reactions: 25 Tests

• CE Marker: Yes
• Detectable Analytes: SARS-CoV-2
• DoA Calibrators: No
• Sample Type: Nasal Swab
• Type: Rapid Test
• For Use With (Application): Fluorescence Immunoassay (FIA)
• Sterility: Sterile